Meagan Gruwell, APRN
Nurse Practitioner · Scottsdale, AZNPI 1386429934
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 90.6% of the total across 318 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 38 manufacturers, the largest accounting for just 18.7% — the pattern of someone who eats at a lot of different presentations. Among nurse practitioner clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 318 payments — averaging $23.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$1K
- Lilly USA, LLC$616
- Novo Nordisk$611
- Insulet Corporation$514
- Bayer$503
- Dexcom, Inc.$434
- plus $3K from 32 others
What the payments were for
- Travel & lodging$5638%
- Food & beverage$6,68591%
- Education$1272%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 21 | $1,380 |
| Lilly USA, LLC | 38 | $616 |
| Novo Nordisk | 53 | $611 |
| Insulet Corporation | 24 | $514 |
| Bayer | 20 | $503 |
| Dexcom, Inc. | 12 | $434 |
| Amgen | 25 | $400 |
| BETA Bionics, Inc. | 17 | $346 |
| Sanofi-aventis U.S. LLC | 10 | $289 |
| AbbVie | 13 | $263 |
| AstraZeneca(2 entities) | 10 | $251 |
| Tandem Diabetes Care, Inc. | 6 | $164 |
| Amneal Pharmaceuticals LLC | 8 | $149 |
| Amphastar Pharmaceuticals, Inc. | 8 | $142 |
| Mannkind Corporation | 6 | $136 |
| Astellas Pharma US Inc | 3 | $130 |
| Ascendis Pharma Endocrinology Inc | 4 | $110 |
| Cequr Corporation | 2 | $103 |
| Ascensia Diabetes Care US Inc. | 6 | $102 |
| Boehringer Ingelheim | 4 | $86 |
| Recordati_rare_diseases_inc. | 3 | $67 |
| Corcept Therapeutics | 2 | $65 |
| Sequel Med Tech, LLC | 1 | $49 |
| Verity Pharmaceuticals Inc. | 3 | $49 |
| Madrigal Pharmaceuticals | 1 | $47 |
| Tolmar, Inc. | 2 | $38 |
| IBSA Pharma Inc. | 2 | $35 |
| Xeris Pharmaceuticals, Inc. | 2 | $35 |
| Radius Health, Inc. | 2 | $34 |
| Neurocrine Biosciences, Inc. | 1 | $33 |
| Embecta Corp. | 1 | $30 |
| Currax Pharmaceuticals LLC | 2 | $30 |
| Kyowa Kirin, Inc. | 1 | $30 |
| Actelion Pharmaceuticals US, Inc. | 1 | $25 |
| Almatica Pharma LLC | 1 | $24 |
| Echosens North America, Inc. | 1 | $21 |
| Acella Pharmaceuticals, LLC | 1 | $19 |
| Shield Therapeutics Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MINIMED 780G$953
- DEXCOM G6 TRANSMITTER$127
- Kerendia$121
- Synthroid$103
How this compares
$7,376 in reported general payments places this provider in the 95th percentile of 1,719 nurse practitioner providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 230 | $398,892 |
| MounjaroTirzepatide | 169 | $278,103 |
| JardianceEmpagliflozin | 161 | $231,136 |
| TrulicityDulaglutide | 82 | $141,868 |
| FarxigaDapagliflozin Propanediol | 57 | $74,976 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 36 | $65,864 |
| JanuviaSitagliptin Phosphate | 43 | $64,452 |
| Tresiba Flextouch U-200Insulin Degludec | 40 | $50,394 |
| Tresiba Flextouch U-100Insulin Degludec | 58 | $41,986 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 34 | $39,868 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 26 | $30,907 |
| KerendiaFinerenone | 15 | $28,519 |
| Omnipod Dash Pods (Gen 4)Insulin Pump Cart,cont Inf,bt | 16 | $24,913 |
| Humalog Kwikpen U-100Insulin Lispro | 44 | $20,379 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 13 | $15,557 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity, Humalog, Insulin Lispro | $616 | $433,737310 claims |
| Novo NordiskOzempic | $611 | $398,892230 claims |
| Boehringer IngelheimJardiance, Synjardy Xr | $86 | $246,693174 claims |
| AstraZenecaFarxiga | $251 | $74,97657 claims |
| BayerKerendia | $503 | $28,51915 claims |
| AbbVieSynthroid | $263 | $7,51269 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $149 | $3,733342 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,719 nurse practitioner providers in Arizona.
Other nurse practitioner in Scottsdale
- Kristen HerzogScottsdale$162K
- Kelley RoneScottsdale$29K
- Jill StudyScottsdale$24K
- Jennifer BarbosaScottsdale$21K
- Jessica LoweryScottsdale$16K
- Ronald OrdasScottsdale$8K
- Theresa LongoScottsdale$8K
- Samantha DeberryScottsdale$8K
- Ann MooreGlendale$208K
- Sandra KurtinTucson$201K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.